Lab for Noncoding RNA & Cancer, School of Life Science, Shanghai University, Shanghai 200444, China.
Int J Mol Sci. 2022 Jul 31;23(15):8518. doi: 10.3390/ijms23158518.
Lung cancer is the leading cause of cancer death worldwide. miR-199a, which has two mature molecules: miR-199a-3p and miR-199a-5p, plays an important biological role in the genesis and development of tumors. We collected recent research results on lung cancer and miR-199a from Google Scholar and PubMed databases. The biological functions of miR-199a in lung cancer are reviewed in detail, and its potential roles in lung cancer diagnosis and treatment are discussed. With miR-199a as the core point and a divergence outward, the interplay between miR-199a and other ncRNAs is reviewed, and a regulatory network covering various cancers is depicted, which can help us to better understand the mechanism of cancer occurrence and provide a means for developing novel therapeutic strategies. In addition, the current methods of diagnosis and treatment of lung cancer are reviewed. Finally, a conclusion was drawn: miR-199a inhibits the development of lung cancer, especially by inhibiting the proliferation, infiltration, and migration of lung cancer cells, inhibiting tumor angiogenesis, increasing the apoptosis of lung cancer cells, and affecting the drug resistance of lung cancer cells. This review aims to provide new insights into lung cancer therapy and prevention.
肺癌是全球癌症死亡的主要原因。miR-199a 有两个成熟分子:miR-199a-3p 和 miR-199a-5p,在肿瘤的发生和发展中发挥着重要的生物学作用。我们从 Google Scholar 和 PubMed 数据库中收集了有关肺癌和 miR-199a 的最新研究结果。详细综述了 miR-199a 在肺癌中的生物学功能,并探讨了其在肺癌诊断和治疗中的潜在作用。以 miR-199a 为核心点向外发散,综述了 miR-199a 与其他 ncRNAs 之间的相互作用,并描绘了一个涵盖各种癌症的调控网络,这有助于我们更好地理解癌症发生的机制,并为开发新的治疗策略提供手段。此外,还对目前肺癌的诊断和治疗方法进行了综述。最后得出结论:miR-199a 抑制肺癌的发展,特别是通过抑制肺癌细胞的增殖、浸润和迁移,抑制肿瘤血管生成,增加肺癌细胞的凋亡,并影响肺癌细胞的耐药性。本综述旨在为肺癌的治疗和预防提供新的思路。